Skip to main content
. 2012 Dec;4(6):650–654. doi: 10.3978/j.issn.2072-1439.2012.10.17

Figure 5.

Figure 5

Changes in tumor marker levels corresponded to the clinical course of disease. PTX. weekly paclitaxel, EC. epirubicin and cyclophosphamide, VINO. vinorelbine, XC. capecitabine and cyclophosphamide.